Key Highlights

  • HCA shares rose 4.88% Tuesday to $408.63, up from a prior close of $389.62.
  • The stock traded in a day range of $392.14 to $408.85 on volume of 1.27 million shares, trading near 52-week highs.
  • Second-quarter revenue of $20.23 billion beat estimates, up 8.7% year-over-year, with adjusted earnings per share of $7.59 also topping expectations.
  • The company trimmed parts of its 2026 EBITDA guidance due to a bigger-than-expected ACA exchange headwind and weaker surgical volumes.
  • Several analysts maintained bullish stances despite lower price targets, including Goldman Sachs at $485, Mizuho at $475 and Leerink at $492.

Shares Extend Rally on Beat-and-Hold Analyst Sentiment

HCA Healthcare (NYSE:HCA) shares surged in Tuesday trading as investors continued to digest last Friday's second-quarter results, which beat estimates on both revenue and adjusted earnings per share. Revenue of $20.23 billion rose 8.7 percent year-over-year, while adjusted earnings per share of $7.59 also topped consensus expectations.

HCA Healthcare is the largest for-profit hospital operator in the United States, founded in 1968 and headquartered in Nashville, Tennessee. The company operates an extensive network of approximately 190 hospitals and more than 2,500 sites of care, including freestanding ambulatory surgery centers, emergency care facilities, urgent care clinics, diagnostic and imaging centers, and psychiatric hospitals across 19 U.S. states and the United Kingdom, with a heavy concentration in Florida and Texas.

Sentiment has been buoyed by several analysts maintaining bullish stances despite lower price targets following the report, with Goldman Sachs setting a target of $485, Mizuho at $475 and Leerink at $492, reinforcing confidence in HCA's margin leadership even after the company trimmed parts of its 2026 EBITDA guidance due to a bigger-than-expected Affordable Care Act exchange headwind and weaker surgical volumes.

Margin Leadership Underpins Bullish Case

HCA carries a market capitalization of approximately $90.65 billion and trades at a forward price-to-earnings ratio of 8.16 and a trailing P/E of 14.11, with reported earnings per share of $28.96. Shares have traded in a 52-week range of $339.82 to $556.52, and the stock offers a dividend yield of 0.74 percent.

The stock's rally also tracks a broader healthcare sector rotation, with the Health Care Select Sector SPDR Fund trading near 52-week highs as investors rotate into defensive healthcare names amid easing macro risk, including a pullback in oil prices and de-escalation in tensions between the United States and Iran. Peer UnitedHealth Group's (NYSE:UNH) guidance raise has also lifted sentiment across managed-care and hospital operators alike, reinforcing HCA's best-in-sector net margins of approximately 8.8 percent.

Conclusion

HCA Healthcare's continued rally reflects analyst confidence in the company's margin leadership even as management trimmed portions of its 2026 EBITDA guidance on ACA exchange and surgical volume headwinds. With shares trading near 52-week highs and broader healthcare sector sentiment improving, investors will be watching for whether the company's cost discipline can offset the flagged near-term pressures.

This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own research before making financial decisions.